Hospitalisations in patients with idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry and EMPIRE Registry
Data from EMPIRE and the IPF-PRO Registry demonstrate the high risk of hospitalisations and mortality among patients with IPF and suggest there may be differences across countries in risk of hospitalisation. Variability in data collection, healthcare systems and clinical practices should be considered when interpreting differences between countries.
Authors
- Jakub Gregor (ORCID: https://orcid.org/0000-0003-2431-7873)
- Will Simmons (ORCID: https://orcid.org/0000-0003-4120-1063)
- P. Lao-Kaim Nick
- Michael Studnicka (ORCID: https://orcid.org/0000-0001-5243-7018)
- Amy L. Olson (ORCID: https://orcid.org/0000-0002-5368-0412)
- Petra Ovesná (ORCID: https://orcid.org/0000-0002-3547-5896)
- Peide Li (ORCID: https://orcid.org/0000-0002-5110-6150)
- Robert J. Kaner (ORCID: https://orcid.org/0000-0003-0527-576X)
- Martina Vašáková (ORCID: https://orcid.org/0000-0002-0424-9941)
- Mary E. Strek (ORCID: https://orcid.org/0000-0002-7671-1023)
- Laurie D. Snyder (ORCID: https://orcid.org/0000-0002-5962-2184)
- Hyun J. Kim (ORCID: https://orcid.org/0000-0002-8247-997X)
- Ying Li (ORCID: https://orcid.org/0000-0001-5429-0080)
Institutions
- University of Minnesota (US)
- Cornell University (US)
- Charles University (CZ)
- Masaryk University (CZ)
- Paracelsus Medical University (AT)
- University of Chicago (US)
- Clinical Research Institute (US)
- Duke Medical Center (US)
- Boehringer Ingelheim (France) (FR)
- Thomayer University Hospital (CZ)
- Boehringer Ingelheim (United States) (US)
- Weill Cornell Medicine (US)
Publication Details
- Journal
- ERJ Open Research
- Published
- 2025-08-28
- DOI
- https://doi.org/10.1183/23120541.00402-2025
- Citations
- 1
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Boehringer Ingelheim
- F. Hoffmann-La Roche